Cann Group is not a CBD oil shop — it is an ASX-listed Australian company that grows and manufactures prescription medical cannabis under licences granted by two federal regulators. If you have searched for cann group cbd oil in Byron Bay or anywhere else in Australia hoping to buy something directly, the short answer is: that is not how this company operates. Cann Group's products travel through a doctor, a prescription and a licensed pharmacy — not through a checkout. This article explains what Cann Group actually does, how prescription medical cannabis reaches patients in Australia, and where an over-the-counter hemp-derived CBD oil from a Byron Bay label fits in a completely separate part of the picture.
FraLa CBD is an independent label based in Byron Bay, NSW — not affiliated with Cann Group, not a licensed producer, and not a clinic. Full corporate details are on Cann Group's official site.
What Cann Group Is (and Isn't)
Cann Group Limited was incorporated in 2014 in Melbourne, Victoria, and is the first company in Australia to hold both a cannabis research licence and a medicinal cannabis cultivation licence. The Office of Drug Control (ODC) issued Cann Group its research licence in February 2017 and its cultivation licence in March 2017 — the earliest dates in the Australian licensed cannabis industry. The company listed on the Australian Securities Exchange under the ticker CAN in May of that same year.
Those licensing milestones are significant because they established Cann Group at the centre of the prescription medical cannabis supply chain before any comparable competitor existed. The company is not a pharmacy, not a telehealth clinic, and not a retail shop. It is a business-to-business (B2B) manufacturer and cultivator: it grows cannabis, extracts and processes it under Good Manufacturing Practice (GMP) conditions, and supplies finished prescription-grade products into the regulated wholesaler and pharmacy network.
There is no direct-to-consumer storefront. No product listing you can browse and add to a cart. The company's public-facing communications are aimed at investors, licensed wholesale partners, and the regulated healthcare system — not at buyers looking for an OTC cannabidiol oil.
Understanding that structure is what makes this review genuinely useful, because cann group cbd oil is one of those search phrases where the intent and the reality don't immediately align. Cann Group produces prescription cannabis medicines. The CBD oil most Australian shoppers are looking for — a hemp-derived, over-the-counter oil you can buy online without a consultation — is a separate product category with a separate regulatory framework.
For a plain-language guide to how Australia classifies these products, the CBD oil laws in Australia guide covers the TGA scheduling system from Schedule 3 through to Schedule 8.
Two Facilities, One Supply Chain
Cann Group operates from two sites in Victoria.
The first is a research and cultivation facility in Bundoora, northern Melbourne. This is where the company's genetics programme and early-stage cultivation work is centred — breeding, trial cultivation, and R&D for new strains and extraction approaches.
The second is a large-scale cultivation and GMP manufacturing facility near Mildura, in north-west Victoria. This is the production engine of the business. The Mildura site includes climate-controlled glasshouse cultivation space, over 12,000 square metres of processing and support facilities, and in-house analytical chemistry and biology laboratories. The facility is licenced for the manufacture of Active Pharmaceutical Ingredients (API), Satipharm capsules (Cann Group's own branded capsule product), and for in-house chemical, physical and microbiological testing under TGA GMP standards.
At its operational capacity, the Mildura facility is designed to produce approximately 12,500 kilograms of dry cannabis flower per year — enough to supply a meaningful fraction of the Australian prescription market. That scale is a reflection of what kind of company Cann Group is: an industrial-grade pharmaceutical manufacturer, not a small producer. Full details of the facilities are on Cann Group's official site.
The ODC (Australia's Office of Drug Control) oversees the cultivation and production licences for medicinal cannabis; the TGA (the Therapeutic Goods Administration) oversees the GMP manufacturing licence and the regulatory framework within which cannabis medicines are produced and prescribed.
How Prescription Medical Cannabis Reaches Patients
Cann Group's products do not reach patients through a direct purchase. The pathway from production line to patient runs through Australia's prescription access frameworks, administered by the TGA.
The two main channels are:
The Special Access Scheme (SAS-B): A TGA-administered pathway under which a doctor can apply to prescribe an unapproved therapeutic good — including prescription cannabis medicines — for an individual patient. The doctor submits an application; the TGA approves or declines. Once approved, the product is dispensed through a licensed pharmacy or dispensary.
Authorised Prescribers (AP): A pathway under which the TGA grants specific doctors the authority to prescribe certain unapproved therapeutic goods to a class of patients without submitting individual applications for each patient.
Both pathways require a doctor's involvement. Telehealth has made it easier for patients to access a cannabis-literate doctor without attending a clinic in person. Telehealth cannabis clinics are the access point many patients use to get a SAS-B consultation — see the Alternaleaf review for an example of how a telehealth cannabis clinic operates. But the consultation and the prescription are always the first steps — there is no shortcut to a Cann Group product.
This is the aspect of Cann Group's business model that most clearly distinguishes it from what FraLa CBD does. Cann Group manufactures for the prescription supply chain. FraLa CBD sells directly to the public as an OTC hemp extract label. Neither is a substitute for the other.
From our CBD oil range
CBG Oil 12000mg – Cannabigerol
Cannabigerol — the cannabinoid the hemp plant uses to make the others as it grows. Less abundant than CBD, which is why CBG oils sit at a different price point. 12000mg in 50ml of MCT carrier (240mg per ml).
CBN Oil 6000mg – Cannabinol
Cannabinol — the cannabinoid that forms as raw hemp ages. 6000mg of CBN isolate in 50ml of MCT oil (120mg per ml). A common choice for evening routines among people already familiar with CBD.
CBD Oil 12000mg – Full Spectrum
The whole-hemp profile — CBD alongside the smaller cannabinoids and terpenes from the same extraction. Trace THC stays under 0.3%. 12000mg in 50ml of MCT oil (240mg per ml).
OTC CBD Oil from Byron Bay: What FraLa CBD Offers
FraLa CBD is a Byron Bay, NSW label that sells five families of hemp-derived CBD oil — all available online, shipped tracked to every Australian state and territory, no prescription and no consultation needed.
The five product families, each described by composition:
- Full-spectrum CBD oil — whole-plant hemp (Cannabis sativa L.) extract in a coconut-derived MCT carrier, retaining the complete cannabinoid and terpene profile including a legal trace of THC (under 0.3%), confirmed by batch Certificate of Analysis.
- Broad-spectrum CBD oil — the same whole-plant extract with THC removed to 0% THC, retaining all other cannabinoids and terpenes.
- CBG oil (1000mg) — cannabigerol (CBG) as the primary compound; a single-cannabinoid product, not a CBD oil.
- CBN oil (1000mg) — cannabinol (CBN) isolate, THC-free, single-compound.
- Pet CBD oil (2000mg) — full-spectrum, pet-formulated, $179.90 AUD.
Entry-point pricing for full-spectrum and broad-spectrum at the 1000mg tier is $89.95 AUD per 50ml bottle. All products are sourced from EU Labs in Amsterdam and tested third-party by batch; a Certificate of Analysis is available on request at enquiries@franklauda.com.
Shipping runs from Byron Bay to Sydney, Melbourne, Brisbane, Perth, Adelaide, Canberra and nationwide. If you are looking for CBD oil in Melbourne specifically, the CBD oil Melbourne page covers delivery specifics for Victoria. The complete range and current prices are in the shop.
From a Byron Bay perspective, FraLa CBD sits in a different category entirely from a licensed producer like Cann Group: smaller scale, direct-to-consumer, OTC hemp extract, no pharmaceutical licensing required. For another angle on Australian CBD oil producers and how the supply chain looks, the Tasmanian Botanics review is worth reading alongside this one.
Two Different Routes in Australia
The clearest way to put the distinction:
Cann Group — ASX-listed B2B manufacturer of prescription medical cannabis; GMP-licenced facilities in Bundoora and Mildura, Victoria; products travel through a doctor, a TGA-regulated access pathway, and a licensed pharmacy; no consumer-facing storefront; official site: canngrouplimited.com.
FraLa CBD — independent Byron Bay OTC label; hemp-derived cannabidiol oil in five families; bought directly online; no consultation; shipped tracked across Byron Bay, NSW and all of Australia from $89.95.
These frameworks coexist. Neither replaces the other. If you are seeking prescribed medical cannabis with a doctor's involvement, the TGA's access pathways — and a telehealth clinic like the ones reviewed in the Alternaleaf article — are where to start. If you want to buy a hemp-derived CBD oil directly without a consultation, the FraLa CBD shop is in one place.
Common Questions About Cann Group and CBD Oil in Byron Bay
Can I buy from Cann Group directly? No. Cann Group is a B2B licensed producer that supplies prescription medical cannabis into the regulated supply chain. There is no consumer storefront. Its products reach patients through a doctor's prescription and a licensed dispensary — not through a direct purchase.
Is Cann Group listed on the ASX? Yes. Cann Group Limited trades on the Australian Securities Exchange under the ticker CAN. It was listed in May 2017 after receiving Australia's first medicinal cannabis licences earlier that year.
What does Cann Group actually manufacture? Cann Group cultivates cannabis and produces GMP-grade prescription cannabis medicines, including Satipharm capsules, at its Mildura facility. The facility is licenced for manufacturing Active Pharmaceutical Ingredients (API) under TGA standards.
Do I need a prescription to buy CBD oil from FraLa CBD? No. FraLa CBD sells hemp-derived, over-the-counter CBD oil directly — no doctor, no prescription, no consultation. It is a different regulatory category from what Cann Group produces. The CBD oil laws in Australia guide explains the scheduling in full.
What is the difference between a prescription cannabis producer and an OTC CBD oil shop? A licensed producer like Cann Group manufactures prescription-grade cannabis medicines for the TGA-regulated supply chain — products that require a doctor and a script. An OTC shop like FraLa CBD sells hemp-derived cannabidiol oil directly to adults, described by spectrum and milligrams, with no prescription needed. Two separate frameworks, two separate product categories.
Is CBD oil legal in Byron Bay, NSW? Within Australia's national framework, yes: low-dose cannabidiol was down-scheduled by the TGA in 2021, and hemp-derived CBD oil is sold online across New South Wales and all other states. The current regulatory picture is covered in the CBD oil laws in Australia 2025 guide. The TGA website is the authoritative source for current scheduling.
